Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Viracta Therapeutics, Inc.
Scientific Title
An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas